Provexis PLC (PXS)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.605p

Buy

0.70p

arrow-down-0.0175p (-2.61%)

Prices updated at 12 Dec 2025, 13:00 GMT

Prices minimum 15 mins delay

Prices in GBX

Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	801,964	1m
	283,795	532,940
	-603,592	-451,971
	-75.26	-34.98
	-586,243	-452,720
	-603,592	-451,971
Sales, General and administrative	464,614	490,969
Interest expenses	-	-
Provision for income taxes	-13,880	3,083
Operating expenses	887,387	984,911
Income before taxes	-601,998	-449,637
Net income available to common shareholders	-586,243	-452,720
	-0.0003	-0.0002
Net interest income	1,594	2,334
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-0.0003	-0.0002
Free cash flow per share	-0.0001	-0.0001
Book value/share	0.0004	0.0006
Debt equity ratio	-	-

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	498,036	1m
Current liabilities	307,448	248,206
Total capital	724,337	1m
Total debt	-	-
Total equity	724,337	1m
Total non current liabilities	-	-
Loans	-	-
Total assets	498,036	1m
Total liabilities	-	-
Cash and cash equivalents	189,357	708,087
Common stock	2,218m	2,346m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	379,121	189,357
Cash dividends paid	-	-
	-191,498	-340,829
Investments (gains) losses	1,734	1,929
	189,357	708,087
Net income	-	-
	-191,498	-340,829
	-	-

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.